ŽATECKÝ, Jan, Oldřich COUFAL, Miloš HOLÁNEK, Otakar KUBALA, Markéta KEPIČOVÁ, Jiří GATĚK, Milan LERCH a Matúš PETEJA. Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging. Turkish Journal of Surgery. 2023, roč. 39, č. 1, s. 1-6. ISSN 2564-6850. doi:10.47717/turkjsurg.2023.5984.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging
Autoři ŽATECKÝ, Jan (203 Česká republika, garant, domácí), Oldřich COUFAL, Miloš HOLÁNEK, Otakar KUBALA, Markéta KEPIČOVÁ, Jiří GATĚK, Milan LERCH a Matúš PETEJA (203 Česká republika).
Vydání Turkish Journal of Surgery, 2023, 2564-6850.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30212 Surgery
Stát vydavatele Turecko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Organizační jednotka Fakulta veřejných politik v Opavě
Doi http://dx.doi.org/10.47717/turkjsurg.2023.5984
Klíčová slova anglicky Breast cancer; sentinel lymph node biopsy; neoadjuvant chemotherapy; axillary dissection; level I axillary dissection
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Lucie Chmelařová, učo 50152. Změněno: 13. 2. 2024 12:35.
Anotace
Objective: The purpose of the study was to investigate the oncological sufficiency of level I axillary dissection for adequate histological nodal staging (ypN) in patients with breast cancer and tumor-involved sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC). Material and Methods: A prospective multicentre pilot study took place from 01.01.2018 to 30.11.2020 in three mammary centres in the Czech Republic in patients with breast cancer after NAC (NCT03556397). Patients in the cohort with positive histological frozen section of SLN were indicated to separate axillary dissection of levels I and II. Results: Sixty-one patients with breast cancer after NAC were included in the study according to inclusion and exclusion criteria. Twelve patients with breast cancer and tumour involved SLN after NAC were further included in the analysis. Two (16.7%) patients had positive non-sentinel lymph nodes in level I only, one (8.3%) patient had positive lymph nodes in level II only, and seven (58.3%) patients had positive lymph nodes in both levels. Level I axillary dissection in a patient with tumour involved SLN after NAC would have resulted in understaging in five (41.7%) patients, mostly ypN1 instead of ypN2. Conclusion: According to our pilot result, level I axillary dissection is not sufficient in terms of adequate histological nodal staging in breast cancer patients after NAC, and level II axillary dissection should not be omitted.
VytisknoutZobrazeno: 27. 2. 2024 21:24